| Literature DB >> 20368802 |
Zhonghui Gai1, Xiaoyu Wang, Xiaorui Liu, Cui Tai, Hongzhi Tang, Xiaofei He, Geng Wu, Zixin Deng, Ping Xu.
Abstract
BACKGROUND: Carbazole is a recalcitrant compound with a dioxin-like structure and possesses mutagenic and toxic activities. Bacteria respond to a xenobiotic by recruiting exogenous genes to establish a pathway to degrade the xenobiotic, which is necessary for their adaptation and survival. Usually, this process is mediated by mobile genetic elements such as plasmids, transposons, and insertion sequences.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20368802 PMCID: PMC2848856 DOI: 10.1371/journal.pone.0010018
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Biodegradation of carbazole via the angular pathway by Sphingomonas sp. XLDN2-5 and other carbazole-utilizing bacteria.
The product in dashed square is unstable and has not been detected. Enzyme names: carbazole 1,9a-dioxygenase (carAaAcfdr); meta-cleavage enzyme (carBaBb); hydrolase (carC); anthranilate 1,2-dioxygenase (antAcAdAbAa). Compound I: carbazole; compound II: 2′-aminobiphenyl-2,3-diol; compound III: 2-hydroxy-6-oxo-6-(2′-aminobiphenyl)-hexa-2,4-dienoic acid; compound IV: 2-hydroxypenta-2,4-dienoate; compound V: anthranilic acid; VI: catechol.
Figure 2Physical maps of car and ant loci.
(A) Physical map of car locus, which is delimited by IS6100 elements. The upstream IS6100 is interrupted by a novel insert element ISSsp1, and was designated IS6100::ISSsp1. (B) Schematic representation of the main features of the novel ISSsp1 sequence in Sphingomonas sp. XLDN2-5. The orientation of the ISSsp1 is shown by an arrow. The red and blue boxes represent the positions of two direct repeats (DR) and two imperfect, 32 bp, terminal inverted repeats (the left inverted repeat [IRL], and the right inverted repeat [IRR]) with one mismatch, which is indicated by lowercase letters. The nucleotide sequences of DRs and IRs are also given. (C) Physical map of ant cluster which is franked by IS6100 elements along a base pair scale.
Coding regions of car locus and ant locus.
| Protein | Position (bp) in sequence (direction) | Length (amino acids) | Putative function | Homologous protein | ||
| % Identity | Protein (accession no.) | Source | ||||
|
| ||||||
| TnpAIS | 1116–1263; 2594–3240 (c) | 264 | Transposase of IS | 100 | Tnp (Q79AS6) |
|
| TnpAIS | 1321–2544 (n) | 407 | Transposase, mutator type | 99 | Tnp (A5VHF2) |
|
| ORF1 | 3272–3400 (n) | 42 | Integrase family protein (truncated, only C-terminal portion) | 100 | ORF7 (Q84IH1) |
|
| CarR | 3621–4301 (c) | 226 | Transcriptional regulator of car operon, GntR family | 99 | CarR (Q84IH0) |
|
| CarAa | 4404–5540 (n) | 378 | Terminal oxygenase component of carbazole 1,9a-dioxygenase | 99 | CarAaI (Q84IG9) |
|
| 60 | CarAa (Q8G8B6) |
| ||||
| CarBa | 5489–5821 (n) | 110 | small subunit of | 100 | CarBaI (Q84IG8) |
|
| CarBb | 5814–6617 (n) | 267 | large subunit of | 99 | CarBbI (Q84IG7) |
|
| 42 | CarBb (Q4TTW1) |
| ||||
| CarC | 6660–7484 (n) | 274 | Meta cleavage compound hydrolase | 99 | CarCI (Q84IG6) |
|
| CarAc | 7525–7854 (n) | 109 | Ferredoxin component of carbazole 1,9a-dioxygenase | 100 | CarAcI (Q84IG5) |
|
| 57 | CarAcII (Q2PFA2) |
| ||||
| ORF8 | 7896–8117 (n) | 74 | TonB-dependent receptor (truncated, only N-terminal portion) | 100 | ORF35 (Q84IG4) |
|
| TnpAIS | 8172–8966 (c) | 264 | Transposase of IS | 100 | Tnp (Q79AS6) |
|
| ORF9 | 8998–9545 (n) | 182 | Putative uncharacterized protein (truncated, only C-terminal portion) | 34 | Q74F08 |
|
| Fdr | 9573–10817 (n) | 407 | Ferredoxin reductase component of carbazole 1,9a-dioxygenase | 62 | FdrI (Q2PF96) |
|
| 59 | FdrII (Q2PF93) |
| ||||
| ORF10 | 10936–11486 (c) | 182 | Transcriptional regulator, TetR family (truncated, only C-terminal portion) | 40 | Q1NF20 |
|
| TnpAIS | 11541–12335 (c) | 264 | Transposase of IS | 100 | Tnp (Q79AS6) |
|
|
| ||||||
| TnpAIS | 55–849 (c) | 264 | Transposase of IS | 100 | Tnp (Q79AS6) |
|
| AntR | 1009–1965 (n) | 318 | Transcriptional regulator, AraC family | 100 | AndR (Q0KJU2) |
|
| 41 | AndR (Q84BZ4) |
| ||||
| AntAc | 2163–3446 (n) | 427 | Anthranilate 1,2-dioxygenase large subunit | 100 | AndAc (Q0KJU3) |
|
| 76 | AndAc (Q84BZ3) |
| ||||
| AntAd | 3451–3921 (n) | 156 | Anthranilate 1,2-dioxygenase small subunit | 100 | AndAd (Q0KJU4) |
|
| 59 | AndAd (Q84BZ2) |
| ||||
| AntAb | 3935–4243 (n) | 102 | Ferredoxin component of anthranilate 1,2-dioxygenase | 100 | AndAb (Q0KJU5) |
|
| 53 | AndAb (Q84BZ1) |
| ||||
| AntAa | 4364–5605 (n) | 413 | Ferredoxin reductase component of anthranilate 1,2-dioxygenase | 100 | AndAa (Q0KJU6) |
|
| 40 | AndAa (Q84BZ0) |
| ||||
| TnpAIS | 6183–6977 (n) | 264 | Transposase of IS | 100 | Tnp (Q79AS6) |
|
Figure 3Electrophoresis results of RT-PCR.
carAaBaBb (lane 1), carBbC (lane 2), carCAc (lane 3), fdr (lane 4), antAa (lane 5) and antAcAdAb (lane 6). Samples containing no reverse transcriptase (No RT) are also shown.
Figure 4Biotransformation of substrates and accumulation of products.
(A) Biotransformation of carbazole (-▪-) and accumulation of 2′-aminobiphenyl-2,3-diol (-▾-) by E. coli DH5α harboring pUcarAaAcfdr. (B) Biotransformation of anthranilate (-♦-) and accumulation of catechol (-▴-) by E. coli DH5α harboring pUantAcdba. E. coli DH5α harboring pUC19 (-□- and -◊-) served as controls. The initial concentrations of carbazole and anthranilate were 2 mM and 1 mM, respectively. Values are means of three replicates ± SD.
Figure 5Comparative analyses of car and ant genes from Sphingomonas sp. XLDN2-5 and other strains.
(A) Comparative analysis of car gene cluster from Sphingomonas sp. XLDN2-5 and related strains. The car genes in the three sphingomonads are more than 99% identity to each other; however, only show 60% identity to that from Pseudomonas sp. CA10. (B) Comparative analysis of ant gene cluster from Sphingomonas sp. XLDN2-5 and related strains. The ant genes in strain XLDN2-5 and KA1 are more than 99% identity to each other; however, only show 40–76% identity to that from Burkholderia cepacia DPO1.
Bacterial strains and plasmids used.
| Strain or plasmid | Description | source |
|
| ||
|
| F- | TransGen |
|
| Aerobic, rod shaped, degrades carbazole | Lab stock |
|
| ||
| pUC19 | Ampr
| TaKaRa |
| pMD18-T | Clone vector | TaKaRa |
| pEASY-Blunt | Clone vector | TransGen |
| pBY13 | Ampr; pUC19 with 7.8-kb fragment that hybridized with | This study |
| p6100-a | Ampr; pMD18-T with 1-kb fragment obtained by genome walking | This study |
| p6100-1 | Ampr; pMD18-T with 4.3-kb fragment obtained by IS-based PCR using pIS6100-F1 and pIS6100-R1 | This study |
| p6100-2 | Ampr; pMD18-T with 2.8-kb fragment obtained by IS-based PCR using pIS6100-F1 and pIS6100-R1 | This study |
| P6100-3 | Ampr; pMD18-T with 5.2-kb fragment obtained by IS-based PCR using pIS6100-R1 | This study |
| pUcarAa | Ampr; pUC19 with 1.2-kb SphI-XbaI fragment containing the | This study |
| pUcarAc | Ampr; pUC19 with 0.3-kb XbaI-KpnI fragment containing the | This study |
| pUfdr | Ampr; pUC19 with 1.3-kb KpnI-EcoRI fragment containing the | This study |
| pEcarAaAc | Ampr; Kar, pEASY-Blunt with 1.5-kb fragment containing the | This study |
| pUcarAaAc | Ampr; 1.5-kb SphI-KpnI fragment containing | This study |
| pUcarAaAcfdr | Ampr; 1.5-kb SphI-KpnI fragment containing | This study |
| pUantAcdb | Ampr; pUC19 with 2.1-kb HindIII-EcoRI fragment containing the | This study |
| pUantAcdba | Ampr; pUC19 with 3.5-kb HindIII-EcoRI fragment containing the | This study |